{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:35:33Z","timestamp":1791311733667,"version":"4.3.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007753","name":"University of Eastern Finland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007753","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with hematological malignancies are a heterogeneous group with special palliative care needs. They are known to have many symptoms and frequent emergency room visits and hospitalizations in the end-of-life phase. However, there are limited data about the symptom burden and health care service utilization in different diagnostic groups of hematological malignancies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The purpose of this study was to define the symptom burden and characteristics of the palliative care phase in patients with hematological malignancies in different diagnostic groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study comprised 195 patients with hematological malignancies who were treated in the Kuopio University Hospital palliative care unit and died between 1.1.2015 and 31.12.2023. Patients were divided into four patient groups: myeloma, lymphoma, leukemia and myelodysplastic syndrome or myeloproliferative neoplasm (MDS\/MPN).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>All patient groups had a considerable symptom burden, with many emergency room visits and hospital admissions near death. Furthermore, palliative care involvement occurred late. Fatigue, pain, and dyspnea were the most common symptoms in myeloma and lymphoma patients; fatigue, pain and loss of appetite in leukemia patients and fatigue, dyspnea and depression or anxiety in MDS\/MPN patients in palliative care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patients with hematological malignancies have a significant symptom burden and remarkable palliative care needs at the end of life. More research and awareness of the benefits of palliative care are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00520-026-10429-z","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T06:14:30Z","timestamp":1771913670000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Symptom burden and palliative care in patients with hematologic malignancies: a single-center experience"],"prefix":"10.1007","volume":"34","author":[{"given":"Annasofia","family":"Holopainen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taru","family":"Kuittinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristiina","family":"Tyynel\u00e4-Korhonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamarja","family":"Lamminm\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"10429_CR1","unstructured":"WHO (2020) Global Atlas of Palliative Care, 2nd Edition, London."},{"key":"10429_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/bjh.18286","volume":"199","author":"A Shaulov","year":"2022","unstructured":"Shaulov A, Aviv A, Alcalde J, Zimmermann C (2022) Early integration of palliative care for patients with haematological malignancies. Br J Haematol 199:14\u201330. https:\/\/doi.org\/10.1111\/bjh.18286","journal-title":"Br J Haematol"},{"key":"10429_CR3","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1001\/jamaoncol.2020.6343","volume":"7","author":"A El-Jawahri","year":"2021","unstructured":"El-Jawahri A, LeBlanc TW, Kavanaugh A et al (2021) Effectiveness of integrated palliative and oncology care for patients with acute myeloid leukemia: a randomized clinical trial. JAMA Oncol 7:238\u2013245. https:\/\/doi.org\/10.1001\/jamaoncol.2020.6343","journal-title":"JAMA Oncol"},{"key":"10429_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000495424","volume":"42","author":"K Oechsle","year":"2019","unstructured":"Oechsle K (2019) Palliative care in patients with hematological malignancies. Oncol Res Treat 42:25\u201330. https:\/\/doi.org\/10.1159\/000495424","journal-title":"Oncol Res Treat"},{"key":"10429_CR5","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1200\/JCO.18.02386","volume":"38","author":"A El-Jawahri","year":"2020","unstructured":"El-Jawahri A, Nelson AM, Gray TF et al (2020) Palliative and end-of-life care for patients with hematologic malignancies. J Clin Oncol 38:944\u2013953. https:\/\/doi.org\/10.1200\/JCO.18.02386","journal-title":"J Clin Oncol"},{"key":"10429_CR6","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1089\/jpm.2019.0332","volume":"22","author":"JA Webb","year":"2019","unstructured":"Webb JA, Foxwell AM, Jones CA et al (2019) Top ten tips palliative care clinicians should know about caring for patients with hematologic malignancies. J Palliat Med 22:1449\u20131454. https:\/\/doi.org\/10.1089\/jpm.2019.0332","journal-title":"J Palliat Med"},{"key":"10429_CR7","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1007\/s00520-021-06560-8","volume":"30","author":"MC Pallotti","year":"2022","unstructured":"Pallotti MC, Rossi R, Scarpi E et al (2022) Patients with multiple myeloma referred for palliative care consultation: from retrospective analysis to future directions to improve clinical outcomes. Support Care Cancer 30:2293\u20132298. https:\/\/doi.org\/10.1007\/s00520-021-06560-8","journal-title":"Support Care Cancer"},{"key":"10429_CR8","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jpainsymman.2010.12.008","volume":"42","author":"V Manitta","year":"2011","unstructured":"Manitta V, Zordan R, Cole-Sinclair M et al (2011) The symptom burden of patients with hematological malignancy: a cross-sectional observational study. J Pain Symptom Manage 42:432\u2013442. https:\/\/doi.org\/10.1016\/j.jpainsymman.2010.12.008","journal-title":"J Pain Symptom Manage"},{"key":"10429_CR9","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1016\/S2352-3026(15)00111-8","volume":"2","author":"TW LeBlanc","year":"2015","unstructured":"LeBlanc TW, Smith JM, Currow DC (2015) Symptom burden of haematological malignancies as death approaches in a community palliative care service: a retrospective cohort study of a consecutive case series. Lancet Haematol 2:e334-338. https:\/\/doi.org\/10.1016\/S2352-3026(15)00111-8","journal-title":"Lancet Haematol"},{"key":"10429_CR10","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1002\/cncr.28614","volume":"120","author":"D Hui","year":"2014","unstructured":"Hui D, Didwaniya N, Vidal M et al (2014) Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study. Cancer 120:1572\u20131578. https:\/\/doi.org\/10.1002\/cncr.28614","journal-title":"Cancer"},{"key":"10429_CR11","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1177\/1049909119896533","volume":"37","author":"M-J Verhoef","year":"2020","unstructured":"Verhoef M-J, de Nijs EJM, Ootjers CS et al (2020) End-of-life trajectories of patients with hematological malignancies and patients with advanced solid tumors visiting the emergency department: the need for a proactive integrated care approach. Am J Hosp Palliat Care 37:692\u2013700. https:\/\/doi.org\/10.1177\/1049909119896533","journal-title":"Am J Hosp Palliat Care"},{"key":"10429_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-024-05721-6","volume":"150","author":"C Gebel","year":"2024","unstructured":"Gebel C, Ditscheid B, Meissner F et al (2024) Utilization and quality of palliative care in patients with hematological and solid cancers: a population-based study. J Cancer Res Clin Oncol 150. https:\/\/doi.org\/10.1007\/s00432-024-05721-6","journal-title":"J Cancer Res Clin Oncol"},{"key":"10429_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.soncn.2025.151962","volume":"41","author":"D Moreno-Alonso","year":"2025","unstructured":"Moreno-Alonso D, Garc\u00eda BG, Madrid-Alejos C et al (2025) Bridging the gap: an updated systematic integrative review of palliative care integration in hematological malignancies. Semin Oncol Nurs 41. https:\/\/doi.org\/10.1016\/j.soncn.2025.151962","journal-title":"Semin Oncol Nurs"},{"key":"10429_CR14","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1089\/jpm.2021.0228","volume":"25","author":"PC Johnson","year":"2022","unstructured":"Johnson PC, Markovitz NH, Yi A et al (2022) End-of-life care for older adults with aggressive non-Hodgkin lymphoma. J Palliat Med 25:728\u2013733. https:\/\/doi.org\/10.1089\/jpm.2021.0228","journal-title":"J Palliat Med"},{"key":"10429_CR15","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.leukres.2013.02.009","volume":"37","author":"C Zimmermann","year":"2013","unstructured":"Zimmermann C, Yuen D, Mischitelle A et al (2013) Symptom burden and supportive care in patients with acute leukemia. Leuk Res 37:731\u2013736. https:\/\/doi.org\/10.1016\/j.leukres.2013.02.009","journal-title":"Leuk Res"},{"key":"10429_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08079-x","volume":"21","author":"S Abbasi","year":"2021","unstructured":"Abbasi S, Roller J, Abdallah A-O et al (2021) Hospitalization at the end of life in patients with multiple myeloma. BMC Cancer 21. https:\/\/doi.org\/10.1186\/s12885-021-08079-x","journal-title":"BMC Cancer"},{"key":"10429_CR17","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/bjh.18401","volume":"199","author":"GR Mohyuddin","year":"2022","unstructured":"Mohyuddin GR, Sinnarajah A, Gayowsky A et al (2022) Quality of end-of-life care in multiple myeloma: a 13-year analysis of a population-based cohort in Ontario, Canada. Br J Haematol 199:688\u2013695. https:\/\/doi.org\/10.1111\/bjh.18401","journal-title":"Br J Haematol"},{"key":"10429_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00520-014-2333-x","volume":"23","author":"H-W Cheng","year":"2015","unstructured":"Cheng H-W, Li C-W, Chan K-Y et al (2015) End-of-life characteristics and palliative care provision for elderly patients suffering from acute myeloid leukemia. Support Care Cancer 23:111\u2013116. https:\/\/doi.org\/10.1007\/s00520-014-2333-x","journal-title":"Support Care Cancer"},{"key":"10429_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0312910","volume":"20","author":"E Sk\u00e5reby","year":"2025","unstructured":"Sk\u00e5reby E, F\u00fcrst P, von Bahr L (2025) End-of-life care in hematological malignancies - a nationwide comparative study on the Swedish Register of Palliative Care. PLoS One 20. https:\/\/doi.org\/10.1371\/journal.pone.0312910","journal-title":"PLoS One"},{"key":"10429_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1600-0609.2009.01250.x","volume":"83","author":"AT Johnsen","year":"2009","unstructured":"Johnsen AT, Tholstrup D, Petersen MA et al (2009) Health related quality of life in a nationally representative sample of haematological patients. Eur J Haematol 83:139\u2013148. https:\/\/doi.org\/10.1111\/j.1600-0609.2009.01250.x","journal-title":"Eur J Haematol"},{"key":"10429_CR21","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1177\/10499091221132285","volume":"40","author":"RPC Ebert","year":"2023","unstructured":"Ebert RPC, Magnus MM, Toro P et al (2023) Hematologic malignancies patients face high symptom burden and are lately referred to palliative consultation: analysis of a single center experience. Am J Hosp Palliat Care 40:761\u2013764. https:\/\/doi.org\/10.1177\/10499091221132285","journal-title":"Am J Hosp Palliat Care"},{"key":"10429_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2410-2","volume":"16","author":"C Ramsenthaler","year":"2016","unstructured":"Ramsenthaler C, Osborne TR, Gao W et al (2016) The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multi-centre study. BMC Cancer 16. https:\/\/doi.org\/10.1186\/s12885-016-2410-2","journal-title":"BMC Cancer"},{"key":"10429_CR23","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jpainsymman.2017.04.012","volume":"54","author":"J Porta-Sales","year":"2017","unstructured":"Porta-Sales J, Guerrero-Torrelles M, Moreno-Alonso D et al (2017) Is early palliative care feasible in patients with multiple myeloma? J Pain Symptom Manage 54:692\u2013700. https:\/\/doi.org\/10.1016\/j.jpainsymman.2017.04.012","journal-title":"J Pain Symptom Manage"},{"key":"10429_CR24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1136\/spcare-2023-004524","volume":"14","author":"D Giusti","year":"2024","unstructured":"Giusti D, Colaci E, Pioli V et al (2024) Early palliative care versus usual haematological care in multiple myeloma: retrospective cohort study. BMJ Support Palliat Care 14:291\u2013294. https:\/\/doi.org\/10.1136\/spcare-2023-004524","journal-title":"BMJ Support Palliat Care"},{"key":"10429_CR25","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJMoa1000678","volume":"363","author":"JS Temel","year":"2010","unstructured":"Temel JS, Greer JA, Muzikansky A et al (2010) Early palliative care for patients with metastatic non\u2013small-cell lung cancer. N Engl J Med 363:733\u2013742. https:\/\/doi.org\/10.1056\/NEJMoa1000678","journal-title":"N Engl J Med"},{"key":"10429_CR26","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/S0140-6736(13)62416-2","volume":"383","author":"C Zimmermann","year":"2014","unstructured":"Zimmermann C, Swami N, Krzyzanowska M et al (2014) Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 383:1721\u20131730. https:\/\/doi.org\/10.1016\/S0140-6736(13)62416-2","journal-title":"Lancet"},{"key":"10429_CR27","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.puhe.2023.11.023","volume":"226","author":"Z Shen","year":"2024","unstructured":"Shen Z, Tan Z, Ge L et al (2024) The global burden of lymphoma: estimates from the Global Burden of Disease 2019 study. Public Health 226:199\u2013206. https:\/\/doi.org\/10.1016\/j.puhe.2023.11.023","journal-title":"Public Health"},{"key":"10429_CR28","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-194707","volume":"144","author":"J Jin","year":"2024","unstructured":"Jin J, Ren S, Zhang W et al (2024) Symptom burden and health-related quality of life in patients with aggressive non-Hodgkin lymphoma in China: a cross-sectional study. Blood 144. https:\/\/doi.org\/10.1182\/blood-2024-194707","journal-title":"Blood"},{"key":"10429_CR29","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.72599","volume":"16","author":"N Rafiq","year":"2024","unstructured":"Rafiq N, Khan MH, Sahibzada M et al (2024) Recent developments and challenges in the treatment of acute leukemia and myelodysplastic syndromes: a systematic review. Cureus 16. https:\/\/doi.org\/10.7759\/cureus.72599","journal-title":"Cureus"},{"key":"10429_CR30","doi-asserted-by":"publisher","unstructured":"Iyer N, Doshi K, Kasire SP, et al (2025) Nationwide trends and disparities in end-of-life care for acute myeloid leukemia: a 2019\u20132021 NIS Analysis of Palliative Care Utilization and Hospitalization Costs. Am J Hosp Palliat Care 10499091251353759. https:\/\/doi.org\/10.1177\/10499091251353759","DOI":"10.1177\/10499091251353759"},{"key":"10429_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2022.09.003","volume":"14","author":"M LoCastro","year":"2023","unstructured":"LoCastro M, Sanapala C, Mendler JH et al (2023) Advance care planning in older patients with acute myeloid leukemia and myelodysplastic syndromes. J Geriatr Oncol 14. https:\/\/doi.org\/10.1016\/j.jgo.2022.09.003","journal-title":"J Geriatr Oncol"},{"key":"10429_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2021-002898","author":"L Potenza","year":"2021","unstructured":"Potenza L, Scaravaglio M, Fortuna D et al (2021) Early palliative\/supportive care in acute myeloid leukaemia allows low aggression end-of-life interventions: observational outpatient study. BMJ Support Palliat Care. https:\/\/doi.org\/10.1136\/bmjspcare-2021-002898","journal-title":"BMJ Support Palliat Care"},{"key":"10429_CR33","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s11899-016-0352-z","volume":"11","author":"M Nickolich","year":"2016","unstructured":"Nickolich M, El-Jawahri A, LeBlanc TW (2016) Palliative and end-of-life care in myelodysplastic syndromes. Curr Hematol Malig Rep 11:434\u2013440. https:\/\/doi.org\/10.1007\/s11899-016-0352-z","journal-title":"Curr Hematol Malig Rep"},{"key":"10429_CR34","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1002\/cncr.29913","volume":"122","author":"SA Fletcher","year":"2016","unstructured":"Fletcher SA, Cronin AM, Zeidan AM et al (2016) Intensity of end-of-life care for patients with myelodysplastic syndromes: findings from a large national database. Cancer 122:1209\u20131215. https:\/\/doi.org\/10.1002\/cncr.29913","journal-title":"Cancer"},{"key":"10429_CR35","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.leukres.2007.10.015","volume":"32","author":"DP Steensma","year":"2008","unstructured":"Steensma DP, Heptinstall KV, Johnson VM et al (2008) Common troublesome symptoms and their impact on quality of life in patients with myelodysplastic syndromes (MDS): results of a large internet-based survey. Leuk Res 32:691\u2013698. https:\/\/doi.org\/10.1016\/j.leukres.2007.10.015","journal-title":"Leuk Res"},{"key":"10429_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejon.2025.102868","volume":"76","author":"M Arias-Rojas","year":"2025","unstructured":"Arias-Rojas M, Leiserovich N, Casta\u00f1o M, Carre\u00f1o-Moreno S (2025) Experiences of cancer patients in palliative care with advanced care planning: a systematic review and meta-synthesis of qualitative studies. Eur J Oncol Nurs Off J Eur Oncol Nurs Soc 76. https:\/\/doi.org\/10.1016\/j.ejon.2025.102868","journal-title":"Eur J Oncol Nurs Off J Eur Oncol Nurs Soc"},{"key":"10429_CR37","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1200\/JCO.18.02123","volume":"38","author":"D Hui","year":"2020","unstructured":"Hui D, Bruera E (2020) Models of palliative care delivery for patients with cancer. J Clin Oncol Off J Am Soc Clin Oncol 38:852\u2013865. https:\/\/doi.org\/10.1200\/JCO.18.02123","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10429-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10429-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10429-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:45:10Z","timestamp":1773215110000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-10429-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10429"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-10429-z","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Regional Medical Research Ethics Committee of Eastern Finland Collaborative Area (845\/13.00\/2023).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"241"}}